nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Dysgeusia—Paclitaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Glycopyrrolate—Rhinitis—Docetaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Glycopyrrolate—Nervousness—Paclitaxel—ovarian cancer	0.00195	0.00195	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Docetaxel—ovarian cancer	0.00194	0.00194	CcSEcCtD
Glycopyrrolate—Urticaria—Vinorelbine—ovarian cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Docetaxel—ovarian cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Abdominal pain—Vinorelbine—ovarian cancer	0.00192	0.00192	CcSEcCtD
Glycopyrrolate—Body temperature increased—Vinorelbine—ovarian cancer	0.00192	0.00192	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Docetaxel—ovarian cancer	0.00192	0.00192	CcSEcCtD
Glycopyrrolate—Urethral disorder—Docetaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Pain in extremity—Epirubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Glycopyrrolate—Nausea—Chlorambucil—ovarian cancer	0.0019	0.0019	CcSEcCtD
Glycopyrrolate—Vision blurred—Paclitaxel—ovarian cancer	0.00189	0.00189	CcSEcCtD
Glycopyrrolate—Dizziness—Topotecan—ovarian cancer	0.00188	0.00188	CcSEcCtD
Glycopyrrolate—Affect lability—Epirubicin—ovarian cancer	0.00187	0.00187	CcSEcCtD
Glycopyrrolate—Agitation—Paclitaxel—ovarian cancer	0.00184	0.00184	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00182	0.00182	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Docetaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Flushing—Docetaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Epirubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Vomiting—Topotecan—ovarian cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Mood swings—Epirubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Rash—Topotecan—ovarian cancer	0.00179	0.00179	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00179	0.00179	CcSEcCtD
Glycopyrrolate—Dermatitis—Topotecan—ovarian cancer	0.00179	0.00179	CcSEcCtD
Glycopyrrolate—Headache—Topotecan—ovarian cancer	0.00178	0.00178	CcSEcCtD
Glycopyrrolate—Palpitations—Paclitaxel—ovarian cancer	0.00177	0.00177	CcSEcCtD
Glycopyrrolate—Vomiting—Melphalan—ovarian cancer	0.00177	0.00177	CcSEcCtD
Glycopyrrolate—Dehydration—Epirubicin—ovarian cancer	0.00177	0.00177	CcSEcCtD
Glycopyrrolate—Pain in extremity—Doxorubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Docetaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Glycopyrrolate—Rash—Melphalan—ovarian cancer	0.00176	0.00176	CcSEcCtD
Glycopyrrolate—Dermatitis—Melphalan—ovarian cancer	0.00176	0.00176	CcSEcCtD
Glycopyrrolate—Asthenia—Vinorelbine—ovarian cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Dry skin—Epirubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Convulsion—Paclitaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Glycopyrrolate—Affect lability—Doxorubicin—ovarian cancer	0.00173	0.00173	CcSEcCtD
Glycopyrrolate—Hypertension—Paclitaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Glycopyrrolate—Pruritus—Vinorelbine—ovarian cancer	0.00172	0.00172	CcSEcCtD
Glycopyrrolate—Mental disorder—Docetaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Epirubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Erythema—Docetaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Malnutrition—Docetaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Nausea—Topotecan—ovarian cancer	0.00169	0.00169	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Dry mouth—Paclitaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—ovarian cancer	0.00167	0.00167	CcSEcCtD
Glycopyrrolate—Dysgeusia—Docetaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Glycopyrrolate—Abdominal distension—Epirubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Glycopyrrolate—Nausea—Melphalan—ovarian cancer	0.00165	0.00165	CcSEcCtD
Glycopyrrolate—Confusional state—Paclitaxel—ovarian cancer	0.00165	0.00165	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Glycopyrrolate—Oedema—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Glycopyrrolate—Infection—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Dizziness—Vinorelbine—ovarian cancer	0.00161	0.00161	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Paclitaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Glycopyrrolate—Tachycardia—Paclitaxel—ovarian cancer	0.0016	0.0016	CcSEcCtD
Glycopyrrolate—Skin disorder—Paclitaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Glycopyrrolate—Vomiting—Vinorelbine—ovarian cancer	0.00155	0.00155	CcSEcCtD
Glycopyrrolate—Dysuria—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Glycopyrrolate—Rash—Vinorelbine—ovarian cancer	0.00153	0.00153	CcSEcCtD
Glycopyrrolate—Dermatitis—Vinorelbine—ovarian cancer	0.00153	0.00153	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Glycopyrrolate—Hypotension—Paclitaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Glycopyrrolate—Headache—Vinorelbine—ovarian cancer	0.00152	0.00152	CcSEcCtD
Glycopyrrolate—Palpitations—Docetaxel—ovarian cancer	0.0015	0.0015	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Epirubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Glycopyrrolate—Insomnia—Paclitaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Glycopyrrolate—Pneumonia—Epirubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Glycopyrrolate—Convulsion—Docetaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Hypertension—Docetaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Infestation NOS—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Infestation—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Drowsiness—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Somnolence—Paclitaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Glycopyrrolate—Nausea—Vinorelbine—ovarian cancer	0.00145	0.00145	CcSEcCtD
Glycopyrrolate—Dyspepsia—Paclitaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Epirubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Glycopyrrolate—Dry mouth—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Fatigue—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Sweating—Epirubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Constipation—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Glycopyrrolate—Pain—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Glycopyrrolate—Confusional state—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Glycopyrrolate—Oedema—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Glycopyrrolate—Epistaxis—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Glycopyrrolate—Infection—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Glycopyrrolate—Sinusitis—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00137	0.00137	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—ovarian cancer	0.00137	0.00137	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Glycopyrrolate—Tachycardia—Docetaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Paclitaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Glycopyrrolate—Skin disorder—Docetaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Glycopyrrolate—Rhinitis—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Epirubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Epirubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Urticaria—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Hypotension—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Abdominal pain—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Body temperature increased—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Urethral disorder—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Glycopyrrolate—Insomnia—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Glycopyrrolate—Somnolence—Docetaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Flushing—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Dyspepsia—Docetaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Glycopyrrolate—Fatigue—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Constipation—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Pain—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Asthenia—Paclitaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Glycopyrrolate—Pruritus—Paclitaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Glycopyrrolate—Mental disorder—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Erythema—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Malnutrition—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Flatulence—Epirubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Tension—Epirubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Dysgeusia—Epirubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Glycopyrrolate—Nervousness—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Glycopyrrolate—Body temperature increased—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Glycopyrrolate—Abdominal pain—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Glycopyrrolate—Dizziness—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Glycopyrrolate—Vision blurred—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Glycopyrrolate—Agitation—Epirubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Glycopyrrolate—Vomiting—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Glycopyrrolate—Rash—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Dermatitis—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Headache—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Glycopyrrolate—Palpitations—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Glycopyrrolate—Asthenia—Docetaxel—ovarian cancer	0.000996	0.000996	CcSEcCtD
Glycopyrrolate—Convulsion—Epirubicin—ovarian cancer	0.000994	0.000994	CcSEcCtD
Glycopyrrolate—Hypertension—Epirubicin—ovarian cancer	0.00099	0.00099	CcSEcCtD
Glycopyrrolate—Pruritus—Docetaxel—ovarian cancer	0.000982	0.000982	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—ovarian cancer	0.000975	0.000975	CcSEcCtD
Glycopyrrolate—Nausea—Paclitaxel—ovarian cancer	0.000972	0.000972	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00097	0.00097	CcSEcCtD
Glycopyrrolate—Dry mouth—Epirubicin—ovarian cancer	0.000955	0.000955	CcSEcCtD
Glycopyrrolate—Confusional state—Epirubicin—ovarian cancer	0.000944	0.000944	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—ovarian cancer	0.000938	0.000938	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000936	0.000936	CcSEcCtD
Glycopyrrolate—Oedema—Epirubicin—ovarian cancer	0.000936	0.000936	CcSEcCtD
Glycopyrrolate—Infection—Epirubicin—ovarian cancer	0.00093	0.00093	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—ovarian cancer	0.000919	0.000919	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Epirubicin—ovarian cancer	0.000918	0.000918	CcSEcCtD
Glycopyrrolate—Dizziness—Docetaxel—ovarian cancer	0.000918	0.000918	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—ovarian cancer	0.000916	0.000916	CcSEcCtD
Glycopyrrolate—Tachycardia—Epirubicin—ovarian cancer	0.000914	0.000914	CcSEcCtD
Glycopyrrolate—Skin disorder—Epirubicin—ovarian cancer	0.000909	0.000909	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000905	0.000905	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000897	0.000897	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—ovarian cancer	0.000884	0.000884	CcSEcCtD
Glycopyrrolate—Vomiting—Docetaxel—ovarian cancer	0.000882	0.000882	CcSEcCtD
Glycopyrrolate—Rash—Docetaxel—ovarian cancer	0.000875	0.000875	CcSEcCtD
Glycopyrrolate—Hypotension—Epirubicin—ovarian cancer	0.000875	0.000875	CcSEcCtD
Glycopyrrolate—Dermatitis—Docetaxel—ovarian cancer	0.000874	0.000874	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—ovarian cancer	0.000873	0.000873	CcSEcCtD
Glycopyrrolate—Headache—Docetaxel—ovarian cancer	0.000869	0.000869	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—ovarian cancer	0.000866	0.000866	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000866	0.000866	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—ovarian cancer	0.00086	0.00086	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000849	0.000849	CcSEcCtD
Glycopyrrolate—Insomnia—Epirubicin—ovarian cancer	0.000847	0.000847	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—ovarian cancer	0.000845	0.000845	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—ovarian cancer	0.000841	0.000841	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000837	0.000837	CcSEcCtD
Glycopyrrolate—Somnolence—Epirubicin—ovarian cancer	0.000832	0.000832	CcSEcCtD
Glycopyrrolate—Nausea—Docetaxel—ovarian cancer	0.000824	0.000824	CcSEcCtD
Glycopyrrolate—Dyspepsia—Epirubicin—ovarian cancer	0.000824	0.000824	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—ovarian cancer	0.000809	0.000809	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000808	0.000808	CcSEcCtD
Glycopyrrolate—Fatigue—Epirubicin—ovarian cancer	0.000807	0.000807	CcSEcCtD
Glycopyrrolate—Pain—Epirubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Glycopyrrolate—Constipation—Epirubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—ovarian cancer	0.000783	0.000783	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Epirubicin—ovarian cancer	0.000771	0.000771	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—ovarian cancer	0.00077	0.00077	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000765	0.000765	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—ovarian cancer	0.000762	0.000762	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000748	0.000748	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—ovarian cancer	0.000747	0.000747	CcSEcCtD
Glycopyrrolate—Urticaria—Epirubicin—ovarian cancer	0.000744	0.000744	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Glycopyrrolate—Abdominal pain—Epirubicin—ovarian cancer	0.00074	0.00074	CcSEcCtD
Glycopyrrolate—Body temperature increased—Epirubicin—ovarian cancer	0.00074	0.00074	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000714	0.000714	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000708	0.000708	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Epirubicin—ovarian cancer	0.00069	0.00069	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—ovarian cancer	0.000688	0.000688	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—ovarian cancer	0.000685	0.000685	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—ovarian cancer	0.000685	0.000685	CcSEcCtD
Glycopyrrolate—Asthenia—Epirubicin—ovarian cancer	0.000672	0.000672	CcSEcCtD
Glycopyrrolate—Pruritus—Epirubicin—ovarian cancer	0.000662	0.000662	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000638	0.000638	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—ovarian cancer	0.000621	0.000621	CcSEcCtD
Glycopyrrolate—Dizziness—Epirubicin—ovarian cancer	0.000619	0.000619	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—ovarian cancer	0.000613	0.000613	CcSEcCtD
Glycopyrrolate—Vomiting—Epirubicin—ovarian cancer	0.000595	0.000595	CcSEcCtD
Glycopyrrolate—Rash—Epirubicin—ovarian cancer	0.00059	0.00059	CcSEcCtD
Glycopyrrolate—Dermatitis—Epirubicin—ovarian cancer	0.00059	0.00059	CcSEcCtD
Glycopyrrolate—Headache—Epirubicin—ovarian cancer	0.000586	0.000586	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—ovarian cancer	0.000573	0.000573	CcSEcCtD
Glycopyrrolate—Nausea—Epirubicin—ovarian cancer	0.000556	0.000556	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—ovarian cancer	0.000551	0.000551	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—ovarian cancer	0.000543	0.000543	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—ovarian cancer	0.000514	0.000514	CcSEcCtD
